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Abstract
Background: Recent advances in genomic sequencing have enabled the use of genome sequencing in standard
biological and biotechnological research projects. The challenge is how to integrate the large amount of data in
order to gain novel biological insights. One way to leverage sequence data is to use genome-scale metabolic
models. We have therefore designed and implemented a bioinformatics platform which supports the development
of such metabolic models.
Results: MEMOSys (MEtabolic MOdel research and development System) is a versatile platform for the
management, storage, and development of genome-scale metabolic models. It supports the development of new
models by providing a built-in version control system which offers access to the complete developmental history.
Moreover, the integrated web board, the authorization system, and the definition of user roles allow collaborations
across departments and institutions. Research on existing models is facilitated by a search system, references to
external databases, and a feature-rich comparison mechanism. MEMOSys provides customizable data exchange
mechanisms using the SBML format to enable analysis in external tools. The web application is based on the Java
EE framework and offers an intuitive user interface. It currently contains six annotated microbial metabolic models.
Conclusions: We have developed a web-based system designed to provide researchers a novel application
facilitating the management and development of metabolic models. The system is freely available at http://www.
icbi.at/MEMOSys.
Background
With the assembly of the first whole genome sequences
in the mid-1990s [1], it became possible to identify all
gene products involved in biological processes of an
organism [2], and soon it became obvious that a holistic
approach can provide answers to relevant mechanistic
questions, i.e. by simultaneously studying all processes
and dynamic interactions at molecular level in order to
define entire pathways and predict the behavior of the
investigated systems. The molecular activity of cell com-
ponents is strongly interconnected and needs to be
investigated using a system-level approach to explain
physiological characteristics and dynamic behavior [3].
Over and above, recent development of next generation
sequencing platforms considerably reduces analysis time
and financial effort, which allows a far wider use of
genome sequencing in biological and biotechnological
research. The task at hand is now to integrate the large
amount of data about biological systems into models in
order to gain novel insights into their interconnected
functionality [4].
A well-established approach to analyze high-through-
put results of complex cellular systems is genome-scale
metabolic modeling, as it provides a new way for inves-
tigating molecular processes [5,6]. A metabolic model
aims at assessing the physiological states of an organism
by describing it as the sum of all chemical reactions of a
particular system [7]. Due to the growing number of
sequenced organisms, genome-scale metabolic models
are compiled for more and more organisms, including
over 20 manually curated bacterial species, yeast and
several fungi, as well as components of mammalian cells
[6,8,9]. Genome-scale metabolic models have already
proven to be valuable for strain engineering which aims
at improving production yield and stability [10,11].
Their ability to predict the outcome of gene deletions
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and prognosticate the adaptation of an organism to new
nutritional environments makes them a useful instru-
ment to determine the characteristics of alternative flux
distributions [12]. Future applications of metabolic mod-
els will contribute to the understanding of microbial
genomes and may lead to better diagnostic tests and
therapies for human diseases [13].
The reconstruction of a new model can be supported
by protein homology comparisons with already existing
networks. Therefore, several repositories were created
which provide access to established metabolic models
(e.g.: BioCyc [14], BioModels [15], BIGG [16]). However,
while these databases and web applications allow
researchers to download and query metabolic models,
none of them provides support for the laborious recon-
struction process. Assembling the final version of a
model is an iterative process involving many manual
steps that generate multiple intermediate versions. The
possibility to review all changes, extract previous ver-
sions, and use an intuitive interface to create new
entries would greatly enhance the construction of new
models. Hence, an application supporting the develop-
ment of a model would be of great help to the
community.
Basic requirement for such a model development
application is the support of data standards. The most
prominent standard to describe biological models is the
Systems Biology Markup Language (SBML) [17]. It pro-
vides a common intermediate format that can be used
to define models in regulatory networks, signaling path-
ways, gene regulation networks, and metabolic pathways.
The work of Herrgård et al. [9] focused on combining
existing yeast models into one consensus reconstruction
and published a SBML compliant model where they laid
special emphasis on referencing model components to
persistent databases or using database-independent
annotations, such as SMILES [18] or InChI [19] strings.
These annotations allow the unambiguous identification
of components and solve the problem of comparing
models where an inconsistent naming schema was
applied. Therefore, enzymes should be assigned to dis-
tinct Enzyme Commission classification numbers (EC
numbers) and may be further linked to established and
manually curated databases like KEGG [20]. Moreover,
metabolites should be annotated with unique identifiers
as defined in the ChEBI database [21] and the KEGG
Compound Database [22] to enable unambiguous com-
ponent identification.
The existence of a unified bioinformatics platform
which supports researchers in the construction of new
genome-scale metabolic models and offers sophisticated
query mechanisms accessing the complete developmen-
tal history would be of great interest to the metabolic
research community. Therefore, we have developed a
new application combining all above mentioned func-
tionalities to support research and development of gen-
ome-scale metabolic models. The platform provides
customizable data exchange mechanisms using the
SBML format, an integrated version control system, and
it currently holds six microbial genome-scale metabolic
models.
Implementation
The MEMOSys system was implemented in Java, a plat-
form independent and object-oriented programming
language [23]. The application is based on Java Enter-
prise Edition 5 (Java EE) and uses the JBoss Seam fra-
mework [24]. It features a three-tier architecture
consisting of a presentation-, logic-, and database- layer.
A relational database (PostgreSQL [25] or Oracle [26])
is used as the persistence backend which is accessed by
the Hibernate [27] persistence framework. The logic
layer consists of ordinary Java objects (POJOs) and
Enterprise Java Beans (EJB) deployed on a JBoss [28]
application server. The presentation layer is based on
Java Server Faces (JSF) [29] and the JBoss Richfaces [30]
component library.
The schema of the MEMOSys application has been
designed using the Unified Modeling Language (UML)
[31] (see additional file 1: databaseDiagram.pdf depicting
the database model). The use of a UML representation
improves maintainability as the application architecture
is outright visible and provides an important part of the
system documentation. After finishing the definition of
a database layout the reverse engineering mechanism of
the Seam framework has been used to create a first scaf-
fold of MEMOSys. The resulting application compo-
nents were used as a starting point to implement the
required functionality.
Envers [32] has been used to provide basic functional-
ity for the version control mechanism. The framework
allows easy versioning of persistent classes and is well
integrated into Hibernate. For each annotated entity,
Envers creates an additional table to store its revisions.
A unique revision number is used for all entities to
allow retrieving a view of the database at a certain revi-
sion. The framework provides a rich API which is used
by MEMOSys to search for archived data. In addition,
Hibernate native SQL queries are used to fetch ver-
sioned entities where the API provided by Envers could
not be used.
The libSBML library [33] is used to read and create
SBML files. Furthermore, it has been modified to
include attributes which were not present in exported
files under certain conditions (e.g.: always output stoi-
chiometry information). The modifications included cus-
tomizing the libSBML source code files and adapting
several libSBML wrapper classes.
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The application uses the resource description frame-
work (RDF) and the “Minimum information requested
in the annotation of biochemical models” (MIRIAM)
[34] notation to annotate components with external
references. Each MIRIAM identifier is a single unique
string, which unambiguously references an object in an
external resource (see Figure 1).
Stored data is secured by a user management system
which allows the definition of different user access levels
and offers concurrent access in a multi-centric environ-
ment [35]. Permission checks are performed at all layers
of the application guaranteeing a fine grained and secure
authorization mechanism.
Results
MEMOSys is an application for managing, developing,
and storing genome-scale metabolic models of microbial
organisms. It is a database-centric Java EE application
including a web front-end, a version control system,
comparison functionality, and data exchange mechan-
isms. In the following, the major features of the applica-
tion are described.
Data Model
MEMOSys has been designed to map and store all
properties of a metabolic model in a database. Reactions
are the essential part of a model and their main attri-
butes are name, reactants, and their reversibility. Each
reactant is made up of a metabolite, the stoichiometric
coefficient for that metabolite, and is assigned to a com-
partment. Compartments are arranged in a hierarchy
which is mapped to the database using references to
their parent compartment. Reactions can be assigned to
a subsystem which is a representation of a certain
metabolic pathway. To support users in the creation or
adaptation of reactions, MEMOSys provides a balance
check mechanism that validates the elemental composi-
tion of consuming and producing reactants (see Figure
1).
In addition to general properties like name and EC
number, reactions are linked to citations in order to
provide primary literature evidence. Genes and their
relationship to other genes and reactions can be
described using Boolean operators and hierarchical
structures (e.g.: gene1 AND [gene2 OR gene3]). For
genes having a reference to the UniProt database [36],
the system provides a mechanism to download the
amino acid sequence of the transcribed protein and dis-
play additional information.
The model is represented in the database by a name,
its unique model id, and containing reactions. It speci-
fies an organism and may contain references to an
image that graphically represents the metabolic map.
Compartments, metabolites, genes, and reactions may
include several references to external databases using
the MIRIAM notation. MEMOSys automatically trans-
forms MIRIAM annotations to web addresses and dis-
plays links to the external references. Moreover, the
application includes a mechanism to easily define addi-
tional external databases which can be referenced by
components. The reference itself can be provided either
as a MIRIAM annotation or as plain hyperlink.
Version control
The development of a metabolic model is an iterative
task producing several intermediate versions until the
final model is established. Therefore, the application
includes an automatic version control system that stores
Figure 1 Edit and view reactions. The edit view (a) uses a balance check mechanism to check the equilibrium of production and
consumption and highlights missing or overproduced components. EC Number and KEGG Id input fields are examples of inserted MIRIAM
identifiers. The detail view (b) of a reaction displays the full chemical equation and transforms MIRIAM identifiers into links that open the
corresponding external resource page.
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each modification as a new revision. Except for static
information like file uploads, all entities and their refer-
ences are included in the version control system. This
allows researchers to retrieve the complete model at any
revision and query, compare, and export previous ver-
sions of a model. MEMOSys provides a function to dis-
play the history of all version controlled entities
including a list of modifications between each version,
which allows researchers to track development changes
(see Figure 2). The home screen (see Figure 3) of the
application lists the latest modifications for metabolites
and reactions which gives users a first overview about
recent updates.
Model selection
The home screen of the application displays a list of all
available models and allows the selection of specific ver-
sions. Since each reaction belongs to a model, the sys-
tem allows users to restrict reaction queries to currently
selected models and examine reactions of only one
model or several models at once. The model selection is
taken into account by all reaction queries and the quick
search functionality.
Quick search
The quick search field, located beneath the navigation
menu on the start page, queries for several entities at
once:
• Reactions are searched for abbreviation, name, EC
number, enzyme, ORF, and KEGG ID.
• Metabolites are searched for abbreviation, name,
formula, ChEBI ID, and KEGG ID.
• Genes are searched for abbreviation, name, EC
number, KEGG ID, and UniProt ID
• Organisms are searched for name.
For each entity type the result page displays lists of
found items and provides links to referenced objects.
Data exchange
MEMOSys features import and export of metabolic
models that are stored in the SBML format.
MEMOSys allows export of all available versions of a
model and supports restricting the exported reactions
by either including only reactions that are in certain
subsystems, or using the result of a reaction query as
input for the export mechanism. Furthermore, the
export functionality defines three different ways to
assign reactions and metabolites to compartments (com-
partmentalization):
• Completely Compartmentalized - reactions and
metabolites are assigned to compartments as they
are stored in the database.
• Partially Decompartmentalized - reactions and
metabolites assigned to compartments which are
within the cytoplasm (e.g.: peroxisome, nucleus) are
reassigned to the cytoplasm. All other compartments
are still present in the exported model.
• Fully Decompartmentalized - the exported model
contains no compartments resulting in an unsegre-
gated system.
Currently, MEMOSys supports export of models into
valid SBML files that contain either all stored informa-
tion about a model or are optimized for usage in the
COBRA toolbox [37]. In addition to the SBML export
functionality, metabolite and reaction lists can be
exported into Excel or PDF files for further use.
Figure 2 Entity discussions and history. The top part of the figure lists the discussions about the current reaction. The lower part shows its
history including the latest modifications. For each version a comment, the timestamp, the user, and the differences to the last version are
shown. The currently selected version is marked using a gray background color.
Pabinger et al. BMC Systems Biology 2011, 5:20
http://www.biomedcentral.com/1752-0509/5/20
Page 4 of 9
Model comparison
Great attention has been paid to the implementation of a
model comparison functionality. The application allows
researchers to compare any version of two different mod-
els. Moreover, it is possible to compare two versions of
the same model to identify development changes. Reac-
tions are compared based on their KEGG ID if available
for both reactions. Otherwise the system uses the chemi-
cal equation (reversibility, metabolites, and their stoichio-
metry) for comparison. Metabolites are compared based
on their ChEBI ID, KEGG ID, and their name. Genes are
compared based on their UniProt ID and their name.
The first section of the comparison result displays a
summary of the detected differences (see Figure 4) and
shows Venn diagrams for reactions, metabolites, and
genes. Next, restrictions on the used models can be applied
to limit the results to selected compartments and subsys-
tems. In addition to the graphical representation, the appli-
cation shows detailed lists of equal and unique entities for
each model and provides tabs to switch between reactions,
metabolites, and genes. Furthermore, reactions, metabo-
lites, and genes are linked to the corresponding pages
which display detailed information about the components.
User access
MEMOSys is designed as a multi-user application which
is capable of handling concurrent accesses due to the
used enterprise application framework. It defines four
different user classes to control data access (see
Table 1). Unregistered visitors are allowed to view only
accepted, publicly available versions of a model. Regis-
tered users are able to browse in addition to publicly
available models, accepted versions of assigned models.
Furthermore, for registered users certain user settings
are persisted in the database to increase the usability of
the application. Editors are able to create, update, and
delete entities of assigned models in the database. More-
over, they have access to their unpublished models, are
allowed to upload files to the web server, and import
SBML models into the database. Administrators are edi-
tors, which have access to all models, are able to accept
modifications of entities, and change the public avail-
ability of models.
Supervision
Each modification of an object is at first marked as pend-
ing and needs to be confirmed by an administrator. The
system provides a clean user interface to accept pending
changes. Every time an administrator approves modifica-
tions, a new version number is assigned to the model. In
addition to the internal revision number provided by the
auditing system, models contain a user defined version
number which can be set by administrators. MEMOSys
differentiates between two access types for models:
Figure 3 Home screen. This figure illustrates the home screen of the application where users can select models and versions used in the
reaction view and quick search functionality. The page displays the latest modifications of reactions and metabolites and shows the newest
comments on the web board (collapsed in the figure).
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(a) public available models are visible to all visitors and
contain only accepted modifications; (b) assigned models
are only visible to registered users and editors of the par-
ticular models.
Web board
The integrated web board allows researchers to create
general threads and attach discussions to stored entities.
On every entity page a list of currently attached threads
is shown, and new discussions can be added to the
object. The latest comments of all discussions are dis-
played on the home screen to quickly update users
about new topics. Administrators are able to mark
threads as sticky to permanently display them on top of
the thread list.
Model integration
The developed application has been filled with several
well-annotated reconstructions of metabolic models.
Each reconstruction was manually reviewed in accor-
dance with the model developers and has been
improved to be stored as a valid SBML file.
The following models are currently stored in the
system:
• iWV1314- Aspergillus oryzae [38]
• iMA871 - Aspergillus niger [39]
• iHD666 - Aspergillus nidulans [40]
• iFF708 - Saccharomyces cerevisiae [41]
• iIN800 - Saccharomyces cerevisiae [42]
• ymn2_0 - Saccharomyces cerevisiae [9]
Table 1 User classes in MEMOSys
User class Browse models Edit model Export
model
Import
model
Modification
approval
Unregistered
visitors
All accepted versions of publicly available models - ✓ - -
Registered
users
All accepted versions of publicly available and assigned models - ✓ - -
Editor All accepted versions of publicly available models and all versions
of assigned models
All assigned
models
✓ ✓ -
Administrator All models All models ✓ ✓ ✓
Figure 4 Visualization of a comparison result. Displayed is a graphical representation of a model comparison result. It shows the area
accurate Venn diagrams for reactions, metabolites, and genes, and provides a short quantitative description of the differences between the
models. In the next stage the result list can be restricted by the selection of subsystems or compartments.
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Additional models will be included in the future.
Moreover, authors are encouraged to provide their mod-
els in order to enlarge the repository.
Discussion
We have developed a bioinformatics platform for the
management, development, and storage of metabolic
models. MEMOSys is aimed at the metabolic research
community to facilitate the study of existing metabolic
models and ease the collaborative development of
new ones.
Blazeck and Alper [43] and Risso et al. [44] state that
the development of new metabolic networks is an itera-
tive process where the possibility to reproduce each
development step is an important prerequisite. There-
fore, MEMOSys features a built-in version control
mechanism that automatically stores the complete his-
tory of a model. The system allows querying and dis-
playing previous versions of a model and provides the
possibility to display the complete history of each com-
ponent. Since certain use cases demand access to speci-
fic versions of a model, the MEMOSys export
mechanism is fully integrated into the version control
system and provides researchers access to the complete
history of a model.
As more and more metabolic models are being gener-
ated, the future development of genome-scale models
will strongly rely on already existing reconstructions of
related organisms. Hence, a flexible and intuitive
mechanism to assess the similarity between models is of
great importance. For this reason, MEMOSys offers a
comparison tool to get an overview of the differences
between two models featuring Venn diagrams and
allowing restricting the comparison to a selection of
subsystems or compartments. As the unique identifica-
tion of components in metabolic models is a prerequi-
site for model comparability and scientific collaborations
[45], special emphasis has been laid on annotating com-
ponents with external references using the MIRIAM
notation.
Over the past years, numerous methods and toolboxes
have been developed to analyze large-scale metabolic
networks [37,46-48]. In order to make use of these
tools, the application provides sophisticated data
exchange mechanisms that allow the export of models
into valid SBML files, which can be, for instance,
directly imported into the widely-used COBRA toolbox.
Furthermore, the application is easily extensible to
include file formats of new analysis tools. MEMOSys
supports several different ways of compartmentalization
which allows researchers to directly use exported mod-
els in analysis tools that do not support a fine-grained
assignment of reactions to compartments.
The development of new metabolic models is facili-
tated by using previously inserted, well annotated com-
ponents that were created during prior reconstruction
processes. Furthermore, due to the flexible export
mechanism certain parts of existing models can be used
as a scaffold for new models. As the development of a
new model is often a collaborative task between several
different institutes, specific prerequisites are required by
the used software. MEMOSys meets these demands by
providing many useful development and collaboration
features. The application supports the definition of user
roles to guarantee that unpublished data is only visible
within a specific group. Furthermore, the application
offers a feature rich editing system and includes a super-
vision mechanism which enforces that modifications are
approved by a key researcher to maintain a high model
quality. The integrated web board facilitates the colla-
borative development as researchers can create either
global threads to discuss general topics, or attach
threads to individual objects to debate specific issues of
a model or its components. Moreover, MEMOSys sup-
ports concurrent access by multiple users and offers an
adjustable user management system for data access
control.
In contrast to the Pathway Tools [49] software system,
which has also been used for the reconstruction of
metabolic pathways [50], MEMOSys offers a rich web-
based editing functionality for all components and cov-
ers change management for relevant model elements by
a built-in version control system. Moreover, its specific
focus lies on supporting the research and development
of metabolic models opposed to the breadth of function-
ality provided by Pathway Tools. Therefore, MEMOSys
is able to offer interfaces and functionalities specifically
optimized for the work with genome-scale metabolic
models.
The developed bioinformatics platform for genome-
scale metabolic models offers a sophisticated version
control system, includes a flexible user management sys-
tem, and is free of charge. Currently existing systems
like the BiGG Database or the BioModels database do
not actively support researchers during the reconstruc-
tion of novel metabolic models by providing an auto-
matic auditing system and a customizable authentication
and authorization system. Furthermore, the developed
application features a state-of-the-art web front-end and
versatile search functionalities, which allow researchers
to perform complex search queries on the stored mod-
els. MEMOSys is not restricted to a particular organism
and is therefore able to manage any metabolic model. It
currently contains six well annotated models which have
been manually curated to be compliant with the SBML
specification.
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Conclusions
In conclusion, the implemented application MEMOSys
provides researchers a tool to store, manage, and
develop metabolic models. The web interface and the
included version control system greatly facilitate
the development of new metabolic models and support
the study of existing one. Furthermore, the authorization
system and the clear definition of user roles allow colla-
borations across departments and institutions. Due to
the flexible and modular software architecture additional
tools and new methods can be easily integrated into the
application.
Availability and requirements
• Project name: MEMOSys
• Project home page: http://www.icbi.at/MEMOSys
also available through http://sysbio.se/BioMet
• Operating system: Solaris, Linux, Windows, Mac
OS X
• Programming language: Java
• Other requirements: Java JDK 1.6.x, Oracle™ 9i or
PostgreSQL™ 8.0.x, a server with at least 1 GB of
main memory available to the application
• License: GNU AFFERO GENERAL PUBLIC
LICENSE
• Any restrictions to use by non-academics: none
The application can be used either by requesting for
an account on the existing server or by performing a
local installation.
The setup of the application should be completed
within a few hours provided the necessary database
access rights are granted. We recommend installing the
application on a central server by a system administra-
tor. Step-by-step instructions are provided at the pro-
ject’s web site together with the necessary files.
Additional material
Additional file 1: MEMOSys database diagram. Depicted is the UML
database diagram of MEMOSys.
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